Z-1743-2022Class III
BIOPHEN UFH Control Plasma
Aniara Diagnostica LLC / initiated 2022-06-28 / Terminated / root cause: labeling and UDI
Aniara Diagnostica LLC began a recall of BIOPHEN UFH Control Plasma on . FDA classified it as Class III and gives the reason as "Incorrect product labeling was included in the package". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.
Recall record
- Recall number
- Z-1743-2022
- Classification
- Class III
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Aniara Diagnostica LLC
- Product
- BIOPHEN UFH Control Plasma
- Product code
- GGN Plasma, Coagulation Control
- Reason for recall
- Incorrect product labeling was included in the package.
- Root cause tag
- labeling and UDI
- FDA root cause
- Under Investigation by firm
- Action
- A recall notification letter was issued on August 3, 2022 to impacted consignees. Consignees were informed that the product is packaged with the incorrect insert ("flyer"). The recalling firm instructs consignees to destroy the included incorrect insert and use the attached correct insert. An Awareness Acknowledgement Form should be completed and returned to the recalling firm acknowledging that the information was received and the incorrect inserts were destroyed.
- Quantity in commerce
- 13 units (1 unit is 1 box)
- Distribution
- Distribution in US - IL and MI
- Product codes and lots
- UDI-DI (GTIN): 03663537008290 Reference No.: 223101; Lot Code: FA2035
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1743-2022 | Class III | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
